Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. ABBV
4. DFTX
5. BAUFF
6. INTC
7. ICE
8. ELDN
9. KR
10. APGE

Go back to Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Regeneron (NASDAQ: REGN) Delayed: 609.94 --0 (-0%)
Previous Close $609.94    52 Week High $592.36 
Open $609.94    52 Week Low $325.35 
Day High $609.94    P/E 160.09 
Day Low $609.94    EPS $3.81 
Volume 3,675